Wilhoit v. AstraZeneca Pharmaceuticals, LP

CourtDistrict Court, D. Delaware
DecidedFebruary 21, 2024
Docket1:22-cv-01634
StatusUnknown

This text of Wilhoit v. AstraZeneca Pharmaceuticals, LP (Wilhoit v. AstraZeneca Pharmaceuticals, LP) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wilhoit v. AstraZeneca Pharmaceuticals, LP, (D. Del. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ROBERT WILHOIT, CHRISTINA ) HARGROVE, GIJI MISCHEL ) DENNARD, JULIE MAGERS, ) MEGAN SMALL, REGINA ) RUSGROVE, and LISA MARSHALL, ) individually, and on behalf of the class ) and all others similarly situated, ) ) Plaintiffs, ) Civil Action No, 22-1634-GBW-SRF ) v. ) ) ASTRAZENECA ) PHARMACEUTICALS, LP, ) ) Defendant. ) REPORT AND RECOMMENDATION Pending before the court in this civil action for violations of the Age Discrimination in Employment Act (“ADEA”), 29 U.S.C. § 621 ef seq., and Title VII of the Civil Rights Act of 1964 (“Title VII”), 42 U.S.C. § 2000e-2 et seq., are the following motions: (1) the partial motion to dismiss the first amended complaint (“FAC”) for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6), filed by AstraZeneca Pharmaceuticals, LP (“Defendant”) (D.1. 22);! (2) the motion to strike the Title VII class claims and the ADEA collective action claims, filed by Defendant (D.I. 25);? and (3) the motion to conditionally certify a collective action under the Fair Labor Standards Act (“FLSA”), 29 U.S.C. § 216(b), filed by plaintiffs Robert Wilhoit, Christina Hargrove, Giji Mischel Dennard, Julie Magers, Megan Small, Regina Rusgrove, and Lisa

! The briefing and filings associated with the pending motion to dismiss are found at D.I. 23, D.I. 24, D.I. 29, and D.I. 33. 2 The briefing and filings associated with the pending motion to strike are found at D.I. 26, D.L. 31, D.I. 32, D.I. 34, D.I. 35, D.I. 36, D.I. 59, D.I. 60, D.I. 61, D.I. 62, and D.I. 64.

Marshall (collectively, “Plaintiffs”) (D.I. 37).* For the following reasons, I recommend that the court GRANT Defendant’s partial motion to dismiss, GRANT Defendant’s motion to strike, and DENY without prejudice Plaintiffs’ motion to conditionally certify a collective action. I BACKGROUND This action arises out of the circumstances surrounding Defendant’s termination of numerous employees who objected to receiving a COVID-19 vaccine on religious grounds. (D.I. 19 at ff 1-2) The FAC alleges that, beginning in 2018, Defendant started pursuing strategies to cultivate a younger workforce. (/d. at 5,34) According to former employees, a large reduction in force occurred in December of 2020, resulting in the termination of approximately 500 employees, most of whom were over 40. (D.I. 38, Ex. E at 8; Ex. H at { 8) In meetings throughout 2021, Defendant emphasized a push to decrease the average age of its employees. (D.I. 19 at Jf 4-5, 30-33) For example, in March of 2021, Defendant’s U.S. Director of Sales, Mike Hartman,’ gave a nationwide sales presentation in which he stated that the average age of Defendant’s employees was too high, and the percentage of employees under age 30 needed to increase. (/d. at 4, 30) In November of 2021, Defendant’s Head of Inclusion and Diversity, Arrastene Henry, shared a region-wide presentation indicating that Defendant would be working to increase the percentage of employees under the age of 30. (/d. at Jf 5, 32) The FAC alleges that Defendant used the COVID-19 pandemic as an opportunity to cull its workforce of older employees by imposing a vaccine mandate it knew would

3 The briefing and filings associated with the motion to conditionally certify a collective action are found at D.I. 38, D.I. 47, D.L 48, D.I. 49, D.I. 50, D.I. 51, D.I. 52, D.I. 53, D.L 54, D.I. 56, DI. 57, and D.L. 58. 4 Defendant disputes the FAC’s characterization of Mr. Hartman’s role, arguing that he led just one of nineteen sales teams for Defendant. (D_I. 47 at 9)

disproportionately impact older, religious employees. (Id. at ]6) Defendant’s efforts began in September of 2021, when a policy was implemented requiring all unvaccinated employees to submit weekly COVID-19 test results. (/d. at □□ 50, 58) Around the same time, Defendant required employees to report their vaccination status. (Jd. at 151) Unvaccinated employees were required to indicate whether they intended to get vaccinated and, if not, to report whether they declined the vaccine for religious, medical, or “other” reasons. (/d.) On January 31, 2022, Defendant announced a mandate requiring all U.S.-based employees to be vaccinated against COVID-19. (/d. at § 63) The announcement set a deadline of February 28, 2022 for employees to request any religious or medical exemptions. (/d. at Jf 63, 79) The FAC alleges that Defendant was aware the vaccine mandate would disproportionately impact older, religious employees based on the survey results from the fall of 2021. (id. at §] 59, 65) Defendant also maintained contact tracing records that showed which employees previously contracted COVID-19 and therefore had natural immunity. (/d. at [] 52, 60) Defendant informed Plaintiffs of its religious accommodation denials on March 31, 2022. (id. at 98) The FAC avers that Defendant failed to use uniform standards to review the requests and responses to secondary questions, and medical exemption requests and accommodations were granted at higher rates than religious requests. (/d. at J] 81-83, 91, 95-99) The denial letters did not identify grounds for questioning the sincerity or religious nature of Plaintiffs’ beliefs. (/d. at { 100-01) Nonetheless, the letters informed Plaintiffs that their employment would be terminated in April of 2022 without severance. (/d. at § 102) On April 29, 2022, Defendant fired more than 200 unvaccinated employees. (Jd. at {| 116)

Plaintiffs brought this lawsuit on December 26, 2022 and filed the FAC on April 10, 2023. (D.L. 1; D.I. 19) The FAC alleges individual and collective causes of action under the ADEA for disparate treatment (Count I) and disparate impact (Count II). (D.1. 19 at f¥ 250- 73)Counts III and IV of the FAC assert causes of action for religious discrimination under Title VII for disparate treatment and/or failure to accommodate. (/d. at J] 274-309) Count II pertains to the “Natural Immunity Religious Class,” defined as all former employees of Defendant who had natural immunity on April 29, 2022 and also sought religious exemptions and accommodations from the vaccine mandate, but were terminated following the denial of their exemption requests. (/d. at { 230) Count IV is brought on behalf of the “Religious Process Class,” defined as all former employees of Defendant who sought religious exemptions and/or accommodations from the vaccine mandate, but were terminated following the denial of their accommodation requests based on an assessment of responses to automated questions. (/d. at J 240) On April 24, 2023, Defendant filed the motion to dismiss Count III of the FAC and a motion to strike the Title VII class claims and the ADEA collective action claims. (D.I. 22; D.I. 25) On September 8, 2023, Plaintiff filed a motion to conditionally certify the collective action. (D.I. 37) The pending motions were referred to the undersigned judicial officer on October 4, 2023. (D.I. 44) II. DISCUSSION A. Partial Motion to Dismiss 1. Legal standard Rule 12(b)(6) permits a party to seek dismissal of a complaint for failure to state a claim upon which relief can be granted. Fed. R. Civ. P. 12(b)(6). To state a claim upon which relief

can be granted pursuant to Rule 12(b)(6), a complaint must contain a “short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P.

Related

General Telephone Co. of Southwest v. Falcon
457 U.S. 147 (Supreme Court, 1982)
Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
Douglas Hodczak v. Latrobe Specialty Steel Co
451 F. App'x 238 (Third Circuit, 2011)
Victor Zavala v. Wal Mart Stores Inc
691 F.3d 527 (Third Circuit, 2012)
Ruehl v. Viacom, Inc.
500 F.3d 375 (Third Circuit, 2007)
Hohider v. United Parcel Service, Inc.
574 F.3d 169 (Third Circuit, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Korman v. Walking Co.
503 F. Supp. 2d 755 (E.D. Pennsylvania, 2007)
Halle v. West Penn Allegheny Health System Inc.
842 F.3d 215 (Third Circuit, 2016)
Richardson v. Verde Energy USA, Inc.
354 F. Supp. 3d 639 (E.D. Pennsylvania, 2018)
Christa Fischer v. Federal Express Corp
42 F.4th 366 (Third Circuit, 2022)
Sincavage v. Barnhart
171 F. App'x 924 (Third Circuit, 2006)
Gaston v. Exelon Corp.
247 F.R.D. 75 (E.D. Pennsylvania, 2007)
Henderson v. Carlson
812 F.2d 874 (Third Circuit, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Wilhoit v. AstraZeneca Pharmaceuticals, LP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wilhoit-v-astrazeneca-pharmaceuticals-lp-ded-2024.